Status:
UNKNOWN
Understanding and Restoring Dopaminergic Function in Fibromyalgia Patients
Lead Sponsor:
University of Fribourg
Collaborating Sponsors:
University of Lausanne
University of Zurich
Conditions:
Fibromyalgia
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
Fibromyalgia (FM) is a very prevalent and debilitating chronic pain disorder that is difficult to treat. Mindfulness-based techniques are regarded as a very promising approach for the treatment of chr...
Detailed Description
the present study is a multi-center randomized controlled trial (RCT) with 3 time points: before the intervention, after completion of the intervention and 3-months after completion of the interventio...
Eligibility Criteria
Inclusion
- Fibromyalgia syndrome
- no psychiatric disorders
- right handed
- older than 18 years,
Exclusion
- male sex
- history of neurological disorders
- left handed
- psychiatric disorders
- current substance or tobacco abuse
- current and past substance dependence
- schizophrenia spectrum disorder
- any other form of chronic pain apart from Fibromyalgia
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04451564
Start Date
March 1 2021
End Date
January 1 2024
Last Update
January 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Fribourg
Fribourg, Switzerland, 1700